InflaRx
IFRX
33 hedge funds and large institutions have $23M invested in InflaRx in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 8 closing their positions.
8% more capital invested
Capital invested by funds: $21.3M → $23M (+$1.67M)
1.07% less ownership
Funds ownership: 23.5% → 22.43% (-1.1%)
11% less funds holding
Funds holding: 37 → 33 (-4)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
+$1.76M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$498K |
| 3 |
EP
Eversept Partners
New York
|
+$384K |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$255K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$72.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$1.76M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.18M |
| 3 |
PCM
Prelude Capital Management
New York
|
-$299K |
| 4 |
Morgan Stanley
New York
|
-$221K |
| 5 |
Millennium Management
New York
|
-$216K |
IFRX Hedge Fund Activity: Q2 2024 in Review
33 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q2 2024, worth a combined $23M — up 7.8% from $21.3M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of IFRX and 4 opened new positions — a net loss of 4 holders — while 9 trimmed existing stakes and 8 added.
The largest buyer was 683 Capital Management, adding an estimated $1.76M. The largest seller was Citigroup, cutting an estimated $1.76M.
- 33 institutional investors held InflaRx (IFRX) as of Q2 2024, down from 37 in Q1 2024.
- Funds reported $23M of InflaRx stock for Q2 2024, up 7.8% quarter-over-quarter.
- 4 funds opened new InflaRx positions in Q2 2024 and 8 closed out, a net change of -4 holders.
- The largest InflaRx buyer in Q2 2024 was 683 Capital Management, an estimated $1.76M added.
- The largest InflaRx seller in Q2 2024 was Citigroup, an estimated $1.76M sold.
Based on aggregated 13F filings for Q2 2024.